407 related articles for article (PubMed ID: 15561276)
1. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
Zhu XH; Chen S; Chen ZK
Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
[TBL] [Abstract][Full Text] [Related]
2. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
Wang J; Zhang L; Tang J; Jiang S; Wang X
Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
[TBL] [Abstract][Full Text] [Related]
4. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
Margenthaler JA; Kataoka M; Flye MW
Transplantation; 2003 Jun; 75(12):2119-27. PubMed ID: 12829922
[TBL] [Abstract][Full Text] [Related]
6. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of skin allograft survival by combined feeding of donor spleen cells and cyclosporine in mice.
Lu X; Zhou L; Chen S
Transplant Proc; 2004 Oct; 36(8):2429-31. PubMed ID: 15561269
[TBL] [Abstract][Full Text] [Related]
8. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
[TBL] [Abstract][Full Text] [Related]
9. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
[TBL] [Abstract][Full Text] [Related]
10. Transferable cardiac allograft acceptance induced by transfusion of donor B cells with impaired inducible costimulator/B7h allorecognition.
Du JF; Wang C; Wang WZ; Li MB; Liang HL; Guan WX
Transplant Proc; 2009 Jun; 41(5):1840-3. PubMed ID: 19545740
[TBL] [Abstract][Full Text] [Related]
11. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
[TBL] [Abstract][Full Text] [Related]
12. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
Gao L; Woo J; Buelow R
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
14. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
15. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ
Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772
[TBL] [Abstract][Full Text] [Related]
16. A combination of donor specific transfusion and rapamycin prolongs cardiac allograft survival in mice.
Wu K; Xiang F; Yuan J; Zeng Z; Zhou H; Chang S; Chen ZK
Transplant Proc; 2008 Dec; 40(10):3699-701. PubMed ID: 19100468
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
18. Spleen plays an important role in maintaining tolerance after removal of the vascularized heart graft.
Chosa E; Hara M; Watanabe A; Matsuzaki Y; Nakamura K; Hamano K; Wood KJ; Onitsuka T
Transplantation; 2007 May; 83(9):1226-33. PubMed ID: 17496540
[TBL] [Abstract][Full Text] [Related]
19. CD4-veCD8-ve CD30+ve T cells are detectable in human lung transplant patients and their proportion of the lymphocyte population after in vitro stimulation with donor spleen cells correlates with preservation of lung physiology.
Polster K; Walker A; Fildes J; Entwistle G; Yonan N; Hutchinson IV; Leonard CT
Transplant Proc; 2005 Jun; 37(5):2257-60. PubMed ID: 15964393
[TBL] [Abstract][Full Text] [Related]
20. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
